EP0557388A4 - Diagnosis and treatment of multiple sclerosis - Google Patents

Diagnosis and treatment of multiple sclerosis

Info

Publication number
EP0557388A4
EP0557388A4 EP19910920470 EP91920470A EP0557388A4 EP 0557388 A4 EP0557388 A4 EP 0557388A4 EP 19910920470 EP19910920470 EP 19910920470 EP 91920470 A EP91920470 A EP 91920470A EP 0557388 A4 EP0557388 A4 EP 0557388A4
Authority
EP
European Patent Office
Prior art keywords
diagnosis
treatment
multiple sclerosis
sclerosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19910920470
Other versions
EP0557388A1 (en
Inventor
Robert David Cook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNIVERSITY Co Pty Ltd
Co Pty Ltd, University of
Original Assignee
UNIVERSITY Co Pty Ltd
Co Pty Ltd, University of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNIVERSITY Co Pty Ltd, Co Pty Ltd, University of filed Critical UNIVERSITY Co Pty Ltd
Publication of EP0557388A1 publication Critical patent/EP0557388A1/en
Publication of EP0557388A4 publication Critical patent/EP0557388A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18421—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
EP19910920470 1990-11-14 1991-11-14 Diagnosis and treatment of multiple sclerosis Withdrawn EP0557388A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU3352/90 1990-11-14
AUPK335290 1990-11-14

Publications (2)

Publication Number Publication Date
EP0557388A1 EP0557388A1 (en) 1993-09-01
EP0557388A4 true EP0557388A4 (en) 1994-07-06

Family

ID=3775068

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910920470 Withdrawn EP0557388A4 (en) 1990-11-14 1991-11-14 Diagnosis and treatment of multiple sclerosis

Country Status (5)

Country Link
EP (1) EP0557388A4 (en)
JP (1) JP3266612B2 (en)
AU (1) AU646522B2 (en)
CA (1) CA2095539A1 (en)
WO (1) WO1992008785A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8183209B2 (en) 2003-05-15 2012-05-22 Dmi Biosciences, Inc. Treatment of T-cell mediated diseases
US8217047B2 (en) 2008-05-27 2012-07-10 Dmi Acquisition Corp. Therapeutic methods and compounds
US8268830B2 (en) 2000-08-04 2012-09-18 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
US8507496B2 (en) 2010-09-07 2013-08-13 Dmi Acquisition Corp. Treatment of diseases
US8980834B2 (en) 2011-10-10 2015-03-17 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK173091D0 (en) * 1991-10-11 1991-10-11 Schleroseforeningen The Danish BIOLOGICAL MATERIALS
GB9310657D0 (en) * 1993-05-24 1993-07-07 Univ London Retrovirus
JP2002511277A (en) * 1998-04-08 2002-04-16 エムエス・リサーチ・アクティーゼルスカブ Diagnosis of multiple sclerosis and other demyelinating diseases
DK1571970T3 (en) * 2002-10-02 2011-11-28 Dmi Biosciences Inc Diagnosis and monitoring of diseases
EP2765968A4 (en) 2011-10-10 2015-01-21 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
JP6231484B2 (en) 2011-10-28 2017-11-15 アンピオ ファーマシューティカルズ，インコーポレイテッド Rhinitis treatment
CA2906864A1 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
JP6723222B2 (en) 2014-08-18 2020-07-15 アンピオ ファーマシューティカルズ，インコーポレイテッド Treatment of joint pathology
EP3310375A4 (en) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ218050A (en) * 1985-11-13 1989-05-29 Wistar Inst Test for the presence of htlv-1v
EP0326395A2 (en) * 1988-01-29 1989-08-02 City Of Hope Method of detecting and identifying certain viral sequences

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BIOLOGICAL ABSTRACTS, vol. 82, no. 2, 1986, Philadelphia, PA, US; abstract no. 15669, R.D. COOK ET AL.: "LIGHT AND ELECTRON MICROSCOPICAL STUDIES OF THE IMMUNOPEROXIDASE STAINING OF MULTIPLE SCLEROSIS PLAQUES USING ANTISERA TO A FELINE-DERIVED AGENT AND GALACTOCEREBROSIDE." page AB-669; *
NEUROPATHOL. APPL. NEUROBIOL., vol. 12, no. 1, 1986, pages 63 - 80 *
See also references of WO9208785A1 *

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8841307B2 (en) 2000-08-04 2014-09-23 Ampio Pharmaceuticals, Inc. Method of using diketopiperazines and composition containing them
US9561226B2 (en) 2000-08-04 2017-02-07 Ampio Pharmaceuticals, Inc. Method of using diketopiperazines and composition containing them
US8268830B2 (en) 2000-08-04 2012-09-18 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
US8916568B2 (en) 2000-08-04 2014-12-23 Ampio Pharmaceuticals, Inc. Method of using diketopiperazines and composition containing them
US8440696B2 (en) 2000-08-04 2013-05-14 Dmi Acquisition Corp. Method of using diketopiperazines and composition containing them
US8455517B2 (en) 2000-08-04 2013-06-04 Dmi Acquisition Corp. Method of using diketopiperazines and composition containing them
US8551953B2 (en) 2003-05-15 2013-10-08 Dmi Acquisition Corp. Treatment of T-cell mediated diseases
US8513196B2 (en) 2003-05-15 2013-08-20 Dmi Acquisition Corp. Treatment of T-cell mediated diseases
US8183209B2 (en) 2003-05-15 2012-05-22 Dmi Biosciences, Inc. Treatment of T-cell mediated diseases
US8324167B2 (en) 2003-05-15 2012-12-04 Dmi Biosciences, Inc. Treatment of T-cell mediated diseases
US8962568B2 (en) 2003-05-15 2015-02-24 Ampio Pharmaceuticals, Inc. Treatment of T-cell mediated diseases
US8969308B2 (en) 2003-05-15 2015-03-03 Ampio Pharmaceuticals, Inc. Treatment of T-cell mediated diseases
US8871772B2 (en) 2008-05-27 2014-10-28 Ampio Pharmaceuticals, Inc. Therapeutic methods and compounds
US9522893B2 (en) 2008-05-27 2016-12-20 Ampio Pharmaceuticals, Inc. Therapeutic methods and compounds
US8217047B2 (en) 2008-05-27 2012-07-10 Dmi Acquisition Corp. Therapeutic methods and compounds
US8507496B2 (en) 2010-09-07 2013-08-13 Dmi Acquisition Corp. Treatment of diseases
US9034878B2 (en) 2010-09-07 2015-05-19 Ampio Pharmaceuticals, Inc. Treatment of diseases
US8980834B2 (en) 2011-10-10 2015-03-17 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
US9060968B2 (en) 2011-10-10 2015-06-23 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease

Also Published As

Publication number Publication date
JP3266612B2 (en) 2002-03-18
AU646522B2 (en) 1994-02-24
WO1992008785A1 (en) 1992-05-29
EP0557388A1 (en) 1993-09-01
CA2095539A1 (en) 1992-05-15
AU8955591A (en) 1992-06-11
JPH06502764A (en) 1994-03-31

Similar Documents

Publication Publication Date Title
SG49658A1 (en) Treatment of condition and disease
EP0542914A4 (en) Improved diagnostic and therapeutic compositions
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
ZA932434B (en) Evaluation and treatment of patients with progressive immunosuppression
EP0584340A4 (en) Diagnosis and treatment of various neuralgias
EP0557388A4 (en) Diagnosis and treatment of multiple sclerosis
EP0506893A4 (en) Diagnosis and treatment of diseases
GB9014307D0 (en) Method of treatment and compositions therefor
GB9006251D0 (en) Monitor of physiological functions
HU9202431D0 (en) Medical preparatives of local application
ZA914435B (en) Treatment of disease
GB9217124D0 (en) Medical treatment
GB9216360D0 (en) Treatment of blood
GB9010190D0 (en) Composition for the treatment of protozoal disease and their use
EG20171A (en) Treatment of conditions and disease
GB2266241B (en) Treatment of pastures
ZA937015B (en) Treatment and diagnosis of cancer
GB9423702D0 (en) Diagnosis and treatment of tumours
RU1833739C (en) Way of treatment hyperekaliemia
CS136289A1 (en) Treatment of bottomsfrom cyclohexanone
ZA934714B (en) Medical use of enzymes
GB2308065B (en) Treatment of multiple sclerosis (MS) and other demyelinating conditions
GB9018875D0 (en) Catalyst and treatment thereof
GB9212535D0 (en) Treatment of boimass
GB9201191D0 (en) Diagnostic and therapeutic compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930610

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19951002

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020628

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1013109

Country of ref document: HK